Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKinsey
Medtronic
Teva
AstraZeneca
Merck
Johnson and Johnson
US Army
Boehringer Ingelheim

Generated: July 18, 2018

DrugPatentWatch Database Preview

Spirapril hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for spirapril hydrochloride and what is the scope of spirapril hydrochloride patent protection?

Spirapril hydrochloride
is the generic ingredient in one branded drug marketed by Schering and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for spirapril hydrochloride
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 11
Clinical Trials: 1
Patent Applications: 369
DailyMed Link:spirapril hydrochloride at DailyMed
Synonyms for spirapril hydrochloride
(2S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,9-dithia-3-azaspiro[4.4]nonane-2-carboxylic acid hydrochloride
(8S)-7((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)-1,4-dithia-7-azaspiro(4.4)nonane-8-carboxylic acid, 1-ethyl ester, monohydrochloride
1,4-dithia-7-azaspiro(4,4)nonane-8-carboxylic acid, 7-(2-((1-ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-,monohydrochloride, (8S-(7(R*(R*)),8R*))-
1,4-Dithia-7-azaspiro(4.4)nonane-8-carboxylic acid, 7-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (8S-(7(R*(R*)),8R*))-
102657-EP2270011A1
102657-EP2272841A1
102657-EP2277879A1
102657-EP2287165A2
102657-EP2287166A2
102657-EP2292620A2
102657-EP2301936A1
94841-17-5
AC1OA87D
AKOS025311425
API0008088
C22H30N2O5S2.HCl
CAS-94841-17-5
CHEMBL1200831
D03765
DSSTox_CID_24272
DSSTox_GSID_44272
DSSTox_RID_80139
DTXSID6044272
LS-178246
NCGC00182545-01
OCC25LM897
Renormax (TN)
Renpress
Sandopril
Sch 33844
SCHEMBL387353
Spirapril HCl
Spirapril hydrochloride (USAN)
Spirapril hydrochloride [USAN]
TI 211-950
Tox21_112981
UNII-OCC25LM897

US Patents and Regulatory Information for spirapril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-003 Dec 29, 1994 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-002 Dec 29, 1994 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-004 Dec 29, 1994 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-001 Dec 29, 1994 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for spirapril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-001 Dec 29, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-003 Dec 29, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-004 Dec 29, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-002 Dec 29, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Covington
Farmers Insurance
UBS
Queensland Health
Fuji
Daiichi Sankyo
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.